Factors predictive of adherence to tuberculosis treatment, Valle del Cauca, Colombia

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 5, 2008, Pages 520-526

  Mateus Solarte, Julio Cesar ^a,b   Carvajal Barona, R ^a  

^a Division Salud   (Colombia)

^b UNIVERSIDAD DEL VALLE   (Colombia)

Author keywords

Adherence; Predictors; Pulmonary tuberculosis; Treatment

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLOMBIA; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLOMBIA; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MOTIVATION; PATIENT COMPLIANCE; ROC CURVE; SOCIOECONOMIC FACTORS; TUBERCULOSIS;

EID: 44049109006     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Dolin P, Raviglione M, Kochi A. Global tuberculosis incidence and mortality in 1990-2000. Bull World Health Organ 1994; 72: 213-220.
2. Raviglione M, Snider D, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 1995; 273: 220-226.
3. World Health Organization. Report on the global tuberculosis epidemic 1998. Geneva, Switzerland: WHO, 1998.
4. Homedes N, Ugalde A. ¿Que sabemos del cumplimiento de los tratamientos medicos en el tercer mundo? Rev Panam Salud Publica 1994; 116: 491-517. [Spanish]
5. Pablos-Mendez A, Knirsch C, Barr R, Lerner B, Frieden T. Non-adherence in tuberculosis treatment: predictors and consequences in New York City. Am J Med 1997; 102: 164-170.
6. Ahllburg D. The economic impact of tuberculosis. Minneapolis, MN, USA: Center for Population Analysis and Policy, University of Minnesota, 2000.
7. Floyd K, Wilkinson D, Gilks C. Comparison of cost-effectiveness of directed observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa. BMJ 1997; 315: 1407-1411.
8. Farmer P, Kim J. Community-based approaches to the control of multidrug resistant tuberculosis: introducing 'DOTS-plus'. BMJ 1998; 317: 671-674.
9. Walley J, Khan M, Newell J. Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan. Lancet 2001; 357: 664-669.
10. Mathema B, Pande S, Jochem K, et al. Tuberculosis treatment in Nepal: a rapid assessment of goverment centres using different types of patients supervision. Int J Tuberc Lung Dis 2001; 5: 912-919.
11. Pungrassami P, Jonsens S, Chongsuvivatwong V, Olsen J, Sorensen H. Practice of directly observed treatment for tuberculosis in southern Thailand: comparison between different types of DOT observers. Int J Tuberc Lung Dis 2002; 6: 389-395.
12. Volmink J, Matchaba P, Garner P. Directly observed therapy and treatment adherence. Lancet 2000; 355: 1345-1350.
13. Glanz K, Rimer B, Lewis F. Health behaviour and health education: theory, research, and practice. 3rd ed. San Francisco, CA, USA: Jossey-Bass, 2002.
14. Fisher J, Fisher W. The information-motivation-behavioral skills model. In: DiClemente R, Crosby R, Kegler M, eds. Emerging theories in promotion practice and research: strategies for improving public health. 1st ed. San Francisco, CA, USA: Jossey-Bass, 2002: pp 40-70.
15. World Health Organization. Adherence to long-term therapies. Evidence for action. Geneva, Switzerland: WHO, 2003.
16. Barnhoorn F, Adriaanse H. In search of factors responsible for non-compliance among tuberculosis patients in Wardha District, India. Soc Sci Med 1992; 34: 291-306.
17. Jaiswal A, Singh V, Ogden J, et al. Adherence to tuberculosis treatment: lessons from the urban setting of Delhi, India. Trop Med Int Health 2003; 8: 625-633.
18. Mejia J, Carmona E. Abandono del tratamiento antituberculoso. Factures asociados. Rev Med IMSS (Mex) 1995; 33: 481-485.
19. Ministerio de Salud. Guía integral de tuberculosis. Resolución 412, por la cual se establecen las actividades, procedimientos e intervenciones de demanda inducida y obligatorio cumplimiento y se adoptan las normas téenicas y guías de atención para el desarrollo de las acciones de protección especifica y detección temprana y la atención de enfermedades de interés en salud pública. Bogotá, Colombia: Minsalud, 2000.
20. Willis G. Cognitive interviewing: a tool for improving questionnaire design. Thousand Oaks, CA, USA: Sage Publications Ltd, 2005.
21. Ministerio de Salud. Resolución No. 8430 de 1993. Por la cual se establecen las normas cientificas, téenicas y administrativas para la investigación en salud. Bogotá, Colombia: Minsalud, 1996.
22. Hosmer D, Lemeshow S. Applied logistic regression. New York, NY, USA: John Wiley & Sons, 1989.
23. Sackett D, Haynes R, Tugwell P, Guyatt G. Clinical epidemiology: a basic science for clinical medicine. Boston, MA, USA: Little, Brown & Co, 1991.
24. Brunton L, Lazo J, Parker K. Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. New York, NY, USA: McGraw-Hill, 2001.
25. Frieden T. Toman's tuberculosis. Case detection, treatment and monitoring. Questions and answers. 2nd ed. Geneva, Switzerland: WHO, 2004.
26. Ferrer X, Kirschbaum A, Toro J, Jadue J, Muñoz M, Espinoza A. Adherencia al tratamiento de la tuberculosis del adulto en Santiago, Chile. Bol Oficina Sank Panam 1991; 111: 423-431.
27. Kleinbaum D, Kupper L, Morgenstern H. Epidemiologic research: principles and quantitative methods. New York, NY, USA: John Wiley & Sons, 1982.
28. Rothman K, Greenland S. Modern epidemiology. 2nd ed. Philadelphia, PA, USA: Lippincott-Raven, 1998.
29. Zklo M, Nieto F. Epidemiology: beyond the basics. Gaithersburg, MD, USA: Aspen Publishers, 2000.
30. Mushlin A, Appel F. Diagnosing potential noncompliance. Physicians' ability in a behavioral dimension of medical care. Arch Intern Med 1977; 137: 318-321.
31. Dick J, VanderWalt H, Hoogendoorn L, Tobias B. Development of a health education booklet to enhance adherence to tuberculosis treatment. Tubercle Lung Dis 1996; 77: 173-177.